Statin Use During Concurrent Chemoradiotherapy for Advanced Nasopharyngeal Cancer
Journal of the National Comprehensive Cancer Network · 2024
DOI: 10.6004/jnccn.2024.7046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2024. Verfasst von Jung-Min Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Cardiovascular Surgery, Taichung Tzu Chi Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Chemoradiotherapy, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Background
The objective of this study was to assess the impact of statin use on overall survival (OS) and nasopharyngeal cancer (NPC)–specific survival in patients with advanced NPC who underwent standard concurrent chemoradiotherapy (CCRT). Patients and Methods: This propensity score matched cohort study used data from the Taiwan Cancer Registry Database and National Health Insurance Research Database to examine the impact of statin use during CCRT on both OS and NPC-specific survival.
Results
Statin use during CCRT demonstrated significant and independent prognostic value for both OS and NPC-specific survival. The adjusted hazard ratio for all-cause mortality in the statin group compared with the nonstatin group was 0.48 (95% CI, 0.34–0.68; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- 1Department of Cardiovascular Surgery, Taichung Tzu Chi Hospital, Taichung, Taiwan.
- 2Department of Surgery, School of Medicine, Tzu Chi University, Hualien, Taiwan.
- 3Department of Hemato-Oncology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
- 4Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
- 5Division of Oral and Maxillofacial Surgery, Department of Dentistry, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
- 6School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
Zitieren
APA
Yu, J. M., Chang, C. L., Lin, K. C., Chen, W. M., Shia, B. C., & Wu, S. Y. (2024). Statin Use During Concurrent Chemoradiotherapy for Advanced Nasopharyngeal Cancer. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2024.7046
Vancouver
Yu JM, Chang CL, Lin KC, Chen WM, Shia BC, Wu SY. Statin Use During Concurrent Chemoradiotherapy for Advanced Nasopharyngeal Cancer. Journal of the National Comprehensive Cancer Network. 2024. doi:10.6004/jnccn.2024.7046
BibTeX
@article{Yu2024,
author = {Yu, Jung-Min and Chang, Chia-Lun and Lin, Kuan-Chou and Chen, Wan-Ming and Shia, Ben-Chang and Wu, Szu-Yuan},
title = {Statin Use During Concurrent Chemoradiotherapy for Advanced Nasopharyngeal Cancer},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2024},
doi = {10.6004/jnccn.2024.7046}
}
EUVIMED